1,1-dichloroethene decreases expression ISO RGD:1313359 6480464 vinylidene chloride results in decreased expression of SOX17 mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:1313359 6480464 ethylene dichloride results in increased expression of SOX17 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1313359 6480464 1, 2-Dimethylhydrazine results in increased expression of SOX17 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1313359 6480464 Estradiol results in decreased expression of SOX17 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:1313359 6480464 ESR1 protein promotes the reaction [Estradiol results in decreased expression of SOX17 mRNA] CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313359 6480464 Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA CTD PMID:19770486 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SOX17 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313359 6480464 Tetrachlorodibenzodioxin affects the expression of SOX17 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313359 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SOX17 mRNA CTD PMID:25975270 3-methylcholanthrene multiple interactions ISO RGD:1313359 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA CTD PMID:23519560 4,4'-diaminodiphenylmethane affects expression ISO RGD:1313359 6480464 4, 4'-diaminodiphenylmethane affects the expression of SOX17 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1313359 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SOX17 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:1313359 6480464 Fenretinide results in increased expression of SOX17 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1313358 6480464 Decitabine results in decreased methylation of SOX17 promoter CTD PMID:18413743 5-aza-2'-deoxycytidine increases expression ISO RGD:1313358 6480464 Decitabine results in increased expression of SOX17 mRNA, Decitabine results in increased expression of SOX17 protein CTD PMID:18413743 5-bromo-2'-deoxyuridine decreases localization ISO RGD:1313358 6480464 Bromodeoxyuridine results in decreased localization of SOX17 protein CTD PMID:24154490 5-fluorouracil decreases expression ISO RGD:1313359 6480464 Fluorouracil results in decreased expression of SOX17 protein CTD PMID:21296659 5-fluorouracil decreases expression ISO RGD:1313358 6480464 Fluorouracil results in decreased expression of SOX17 mRNA CTD PMID:24737281 5-fluorouracil decreases localization ISO RGD:1313358 6480464 Fluorouracil results in decreased localization of SOX17 protein CTD PMID:24154490 6-aminonicotinamide decreases localization ISO RGD:1313358 6480464 6-Aminonicotinamide results in decreased localization of SOX17 protein CTD PMID:24154490 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SOX17 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of SOX17 mRNA CTD PMID:31881176 acetic acid decreases expression ISO RGD:1313359 6480464 Acetic Acid results in decreased expression of SOX17 protein CTD PMID:21296659 actinomycin D decreases localization ISO RGD:1313358 6480464 Dactinomycin results in decreased localization of SOX17 protein CTD PMID:24154490 aflatoxin B1 decreases expression ISO RGD:1313358 6480464 Aflatoxin B1 results in decreased expression of SOX17 mRNA CTD PMID:22100608 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SOX17 mRNA CTD PMID:33354967 aflatoxin B1 decreases methylation ISO RGD:1313358 6480464 Aflatoxin B1 results in decreased methylation of SOX17 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1313359 6480464 Tretinoin results in increased expression of SOX17 mRNA CTD PMID:16236135 all-trans-retinoic acid affects expression ISO RGD:1313358 6480464 Tretinoin affects the expression of SOX17 mRNA CTD PMID:31600526 all-trans-retinoic acid multiple interactions ISO RGD:1313358 6480464 [4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA] CTD PMID:31711903 all-trans-retinoic acid decreases localization ISO RGD:1313358 6480464 Tretinoin results in decreased localization of SOX17 protein CTD PMID:24154490 all-trans-retinol multiple interactions ISO RGD:1313359 6480464 [Vitamin A co-treated with INHBA protein] results in increased expression of SOX17 mRNA CTD PMID:17244017 angiotensin II increases expression ISO RGD:1313358 329853320 Angiotensin II increases expression of SOX17 mRNA and protein in retinal microvascular endothelial cells RGD angiotensin II decreases expression ISO RGD:1313358 329853329 Angiotensin II decreases expression of SOX17 protein in retinal endothelial cells RGD Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of SOX17 mRNA CTD PMID:34858468 arsenite(3-) increases methylation ISO RGD:1313358 6480464 arsenite results in increased methylation of SOX17 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SOX17 mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO RGD:1313358 6480464 Benzo(a)pyrene results in increased methylation of SOX17 3' UTR, Benzo(a)pyrene results in increased methylation of SOX17 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1313359 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1313359 6480464 Benzo(a)pyrene results in increased expression of SOX17 mRNA CTD PMID:19770486 more ... benzo[b]fluoranthene increases expression ISO RGD:1313359 6480464 benzo(b)fluoranthene results in increased expression of SOX17 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1313359 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 Benzo[k]fluoranthene increases expression ISO RGD:1313359 6480464 benzo(k)fluoranthene results in increased expression of SOX17 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA CTD PMID:25031359 bisphenol A increases expression ISO RGD:1313359 6480464 bisphenol A results in increased expression of SOX17 mRNA CTD PMID:24090592 , PMID:30951980 bisphenol A increases expression ISO RGD:1313358 6480464 bisphenol A results in increased expression of SOX17 mRNA CTD PMID:27271280 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SOX17 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SOX17 mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO RGD:1313359 6480464 bisphenol F results in increased expression of SOX17 mRNA CTD PMID:30951980 bromochloroacetic acid decreases expression ISO RGD:1313359 6480464 bromochloroacetic acid results in decreased expression of SOX17 protein CTD PMID:21296659 buta-1,3-diene decreases expression ISO RGD:1313359 6480464 1, 3-butadiene results in decreased expression of SOX17 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:1313358 6480464 butyraldehyde results in increased expression of SOX17 mRNA CTD PMID:26079696 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SOX17 mRNA CTD PMID:19167457 calciol increases expression ISO RGD:1313359 6480464 Cholecalciferol results in increased expression of SOX17 mRNA, Cholecalciferol results in increased expression of SOX17 protein CTD PMID:17170073 camptothecin increases methylation ISO RGD:1313358 6480464 Camptothecin results in increased methylation of SOX17 gene CTD PMID:30720231 carbamazepine affects expression ISO RGD:1313358 6480464 Carbamazepine affects the expression of SOX17 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1313359 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1313358 6480464 CGP 52608 promotes the reaction [RORA protein binds to SOX17 gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO RGD:1313358 6480464 4-(5-benzo(1 more ... CTD PMID:31711903 CHIR 99021 increases expression ISO RGD:1313358 6480464 Chir 99021 results in increased expression of SOX17 mRNA CTD PMID:31711903 Chlorophacinone decreases localization ISO RGD:1313358 6480464 chlorophacinone results in decreased localization of SOX17 protein CTD PMID:24154490 chloroprene decreases expression ISO RGD:1313359 6480464 Chloroprene results in decreased expression of SOX17 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:1313359 6480464 Chlorpyrifos results in increased expression of SOX17 mRNA CTD PMID:34289071 , PMID:37019170 chrysene multiple interactions ISO RGD:1313359 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 columbamine decreases expression ISO RGD:1313358 6480464 columbamine results in decreased expression of SOX17 mRNA CTD PMID:23124089 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of SOX17 mRNA CTD PMID:27523638 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SOX17 mRNA CTD PMID:26577399 diethylstilbestrol increases expression ISO RGD:1313358 6480464 Diethylstilbestrol results in increased expression of SOX17 mRNA CTD PMID:19371625 diethylstilbestrol decreases localization ISO RGD:1313358 6480464 Diethylstilbestrol results in decreased localization of SOX17 protein CTD PMID:24154490 dimethyl sulfoxide decreases expression ISO RGD:1313358 6480464 Dimethyl Sulfoxide results in decreased expression of SOX17 mRNA CTD PMID:22105179 diniconazole decreases localization ISO RGD:1313358 6480464 diniconazole results in decreased localization of SOX17 protein CTD PMID:24154490 dinoseb decreases localization ISO RGD:1313358 6480464 dinoseb results in decreased localization of SOX17 protein CTD PMID:24154490 diquat decreases localization ISO RGD:1313358 6480464 Diquat results in decreased localization of SOX17 protein CTD PMID:24154490 dorsomorphin decreases localization ISO RGD:1313358 6480464 dorsomorphin results in decreased localization of SOX17 protein CTD PMID:24154490 dorsomorphin multiple interactions ISO RGD:1313358 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA CTD PMID:27188386 doxorubicin decreases localization ISO RGD:1313358 6480464 Doxorubicin results in decreased localization of SOX17 protein CTD PMID:24154490 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SOX17 mRNA CTD PMID:29391264 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SOX17 mRNA CTD PMID:30307764 fluazinam decreases localization ISO RGD:1313358 6480464 fluazinam results in decreased localization of SOX17 protein CTD PMID:24154490 flusilazole decreases localization ISO RGD:1313358 6480464 flusilazole results in decreased localization of SOX17 protein CTD PMID:24154490 folic acid decreases expression ISO RGD:1313359 6480464 Folic Acid results in decreased expression of SOX17 mRNA CTD PMID:25629700 gefitinib decreases localization ISO RGD:1313358 6480464 gefitinib results in decreased localization of SOX17 protein CTD PMID:24154490 genistein multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA CTD PMID:25031359 genistein decreases expression ISO RGD:1313359 6480464 Genistein results in decreased expression of SOX17 mRNA, Genistein results in decreased expression of SOX17 protein CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SOX17 mRNA CTD PMID:33387578 hexaconazole decreases localization ISO RGD:1313358 6480464 hexaconazole results in decreased localization of SOX17 protein CTD PMID:24154490 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1313359 6480464 indeno(1 more ... CTD PMID:26377693 isoprenaline increases expression ISO RGD:1313359 6480464 Isoproterenol results in increased expression of SOX17 mRNA CTD PMID:20003209 isotretinoin decreases localization ISO RGD:1313358 6480464 Isotretinoin results in decreased localization of SOX17 protein CTD PMID:24154490 Licochalcone B increases expression ISO RGD:1313358 6480464 licochalcone B results in increased expression of SOX17 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO RGD:1313359 6480464 Lipopolysaccharides results in increased expression of SOX17 mRNA CTD PMID:10975854 maleic acid increases expression ISO RGD:1313358 6480464 maleic acid results in increased expression of SOX17 mRNA CTD PMID:28392987 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA CTD PMID:19564919 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SOX17 mRNA CTD PMID:19564919 mianserin decreases localization ISO RGD:1313358 6480464 Mianserin results in decreased localization of SOX17 protein CTD PMID:24154490 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of SOX17 mRNA CTD PMID:25972201 monocrotaline decreases expression EXP 329853317 Monocrotaline decreases expression of Sox17 protein in the lung RGD N-acetyl-L-cysteine multiple interactions ISO RGD:1313358 329853329 N-acetyl-cysteine inhibits the reaction [angiotensin II decreases expression of SOX17 protein in retinal endothelial cells] RGD N-nitrosodiethylamine decreases expression ISO RGD:1313358 6480464 Diethylnitrosamine results in decreased expression of SOX17 mRNA CTD PMID:21527772 naphthalene increases expression ISO RGD:1313359 6480464 naphthalene results in increased expression of SOX17 protein CTD PMID:16239640 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1313359 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SOX17 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1313359 6480464 Acetaminophen affects the expression of SOX17 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1313358 6480464 Acetaminophen results in decreased expression of SOX17 mRNA CTD PMID:22230336 paraquat increases expression ISO RGD:1313359 6480464 Paraquat results in increased expression of SOX17 mRNA CTD PMID:12595580 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1313359 6480464 perfluorooctane sulfonic acid results in decreased expression of SOX17 mRNA CTD PMID:25510869 phenobarbital affects expression ISO RGD:1313359 6480464 Phenobarbital affects the expression of SOX17 mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO RGD:1313358 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1313359 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA CTD PMID:23519560 remdesivir decreases expression ISO RGD:1313359 6480464 remdesivir results in decreased expression of SOX17 mRNA CTD PMID:35605700 resveratrol decreases expression ISO RGD:1313358 6480464 resveratrol results in decreased expression of SOX17 mRNA CTD PMID:19371625 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of SOX17 mRNA CTD PMID:25905778 ritanserin decreases localization ISO RGD:1313358 6480464 Ritanserin results in decreased localization of SOX17 protein CTD PMID:24154490 SB 431542 decreases localization ISO RGD:1313358 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased localization of SOX17 protein CTD PMID:24154490 SB 431542 multiple interactions ISO RGD:1313358 6480464 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:31711903 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA CTD PMID:19564919 silicon dioxide decreases expression ISO RGD:1313358 6480464 Silicon Dioxide analog results in decreased expression of SOX17 mRNA CTD PMID:25895662 sorafenib decreases localization ISO RGD:1313358 6480464 sorafenib results in decreased localization of SOX17 protein CTD PMID:24154490 sunitinib decreases localization ISO RGD:1313358 6480464 sunitinib results in decreased localization of SOX17 protein CTD PMID:24154490 tetrachloroethene decreases expression ISO RGD:1313359 6480464 Tetrachloroethylene results in decreased expression of SOX17 mRNA CTD PMID:28973375 tetraphene increases expression ISO RGD:1313359 6480464 benz(a)anthracene results in increased expression of SOX17 mRNA CTD PMID:26377693 tetraphene multiple interactions ISO RGD:1313359 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 thalidomide decreases localization ISO RGD:1313358 6480464 Thalidomide results in decreased localization of SOX17 protein CTD PMID:24154490 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SOX17 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1313359 6480464 titanium dioxide results in increased expression of SOX17 mRNA CTD PMID:23557971 toluene increases expression EXP 6480464 Toluene results in increased expression of SOX17 mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA CTD PMID:25729387 trichloroethene decreases methylation EXP 6480464 Trichloroethylene results in decreased methylation of SOX17 gene CTD PMID:27618143 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SOX17 mRNA CTD PMID:33387578 trichloroethene decreases expression ISO RGD:1313359 6480464 Trichloroethylene results in decreased expression of SOX17 mRNA CTD PMID:28013219 triclosan decreases expression ISO RGD:1313358 6480464 Triclosan results in decreased expression of SOX17 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1313359 6480464 trimellitic anhydride results in decreased expression of SOX17 mRNA CTD PMID:19042947 valproic acid decreases localization ISO RGD:1313358 6480464 Valproic Acid results in decreased localization of SOX17 protein CTD PMID:24154490 valproic acid affects expression ISO RGD:1313358 6480464 Valproic Acid affects the expression of SOX17 mRNA CTD PMID:25979313 vandetanib decreases localization ISO RGD:1313358 6480464 vandetanib results in decreased localization of SOX17 protein CTD PMID:24154490 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SOX17 mRNA CTD PMID:19015723 ziprasidone decreases localization ISO RGD:1313358 6480464 ziprasidone results in decreased localization of SOX17 protein CTD PMID:24154490 zoledronic acid increases expression ISO RGD:1313358 6480464 zoledronic acid results in increased expression of SOX17 mRNA CTD PMID:24714768